These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6145520)

  • 21. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
    Lam RW; Jeste SD; Jeste DV
    Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia.
    Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T
    Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia: a review.
    Latimer PR
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S49-54. PubMed ID: 8564917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A summary of current knowledge of tardive dyskinesia.
    Baldessarini RJ
    Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of tardive dyskinesia.
    Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM; Morgenstern H; Doucette JT
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia: a five year follow-up.
    Fornazzari X; Grossman H; Thornton J; Seeman MV
    Can J Psychiatry; 1989 Oct; 34(7):700-3. PubMed ID: 2572317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics.
    Spohn HE; Coyne L; Spray J
    Arch Gen Psychiatry; 1988 Sep; 45(9):833-40. PubMed ID: 2901252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing effector pattern of tardive dyskinesia during the course of neuroleptic withdrawal.
    Newell KM; Wszola B; Sprague RL; Mahorney SL; Bodfish JW
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):262-8. PubMed ID: 11534536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia in older out-patients: a follow-up study.
    Labbate LA; Lande RG; Jones F; Oleshansky MA
    Acta Psychiatr Scand; 1997 Sep; 96(3):195-8. PubMed ID: 9296550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P
    Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up.
    Larach VW; Zamboni RT; Mancini HR; Mancini RR; Gallardo RT
    Schizophr Res; 1997 Dec; 28(2-3):231-46. PubMed ID: 9468357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.